G1 Therapeutics Inc (GTHX)
4.77
-0.21
(-4.22%)
USD |
NASDAQ |
May 10, 16:00
4.77
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Debt to Equity Ratio: 1.554 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 1.554 |
December 31, 2023 | 1.457 |
September 30, 2023 | 1.191 |
June 30, 2023 | 0.8851 |
March 31, 2023 | 1.722 |
December 31, 2022 | 1.120 |
September 30, 2022 | 1.666 |
June 30, 2022 | 1.147 |
Date | Value |
---|---|
March 31, 2022 | 0.7555 |
December 31, 2021 | 0.5238 |
September 30, 2021 | 0.1697 |
June 30, 2021 | 0.1412 |
March 31, 2021 | 0.1219 |
December 31, 2020 | 0.1122 |
September 30, 2020 | 0.0996 |
June 30, 2020 | 0.0954 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0954
Minimum
Jun 2020
1.722
Maximum
Mar 2023
0.7976
Average
0.8203
Median
Debt to Equity Ratio Benchmarks
Amicus Therapeutics Inc | 2.972 |
Geron Corp | 0.2399 |
Palatin Technologies Inc | 0.00 |
Oragenics Inc | -- |
TG Therapeutics Inc | 0.6329 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 102.03M |
Total Liabilities (Quarterly) | 74.29M |
Shareholders Equity (Quarterly) | 27.74M |
Current Ratio | 2.940 |
Net Debt Paydown Yield | 3.01% |